Shaping the Future of Clinical Studies in Croatia

We are thrilled to have attended the "Clinical Studies – Perspectives and Challenges" conference organized by HUBOL (Croatian Association of Clinical Research Professionals). This event brought together key stakeholders from the pharmaceutical industry, regulatory bodies, and clinical research organizations to discuss the future of clinical studies in Croatia.

Key Highlights

The conference addressed several critical topics:

• The current state of clinical research in Croatia
• Regulatory framework and recent updates from the Agency for Medicinal Products and Medical Devices (HALMED)
• Opportunities for Croatia to attract more international clinical trials
• The role of digitalization in modernizing clinical study management
• Collaboration between hospitals, CROs, and pharmaceutical companies

LabSense's Role

As a laboratory service provider committed to supporting clinical research, LabSense sees significant potential in expanding our GCLP-compliant analytical services to support clinical trials conducted in Croatia and the wider region.

We are grateful for the opportunity to engage with this community and contribute to shaping the future of clinical research in Croatia.